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We describe the introduction of various multi-drug 
resistant bacterial strains, including an NDM-1-
producing Klebsiella pneumoniae, through a traveller 
returning from Egypt, where they had been admitted 
to a private hospital. All family members of the patient 
were colonised with one or more extended-spectrum 
beta-lactamase producing strains. These findings 
emphasise the importance of adherence to isolation 
precautions for returning patients and suggest the 
need for inclusion of Enterobacteriaceae in admission 
screening.
We here report of a patient who had been hospitalised 
in Egypt for appendicitis in July 2013, and was colo-
nised with various multiresistant Enterobacteriaceae 
including strains producing NDM-1, oxacillinase-48 
(OXA-48) and extended spectrum beta-lactamase 
(ESBL). Explorative screening for multiresistant micro-
organisms among the patient’s family members also 
yielded several ESBL-producing microorganisms. This 
report addresses the need for heightened awareness 
of patients and family members who have recently 
been exposed to healthcare environments in countries 
with high levels of antibiotic resistance. 
Patients repatriated after hospitalisation abroad are a 
risk for introducing multiresistant microorganisms into 
hospitals in their home countries. In 2008, New Delhi 
metallo-beta-lactamase (NDM), which hydrolyses last-
line carbapenem antibiotics, has been for the first time 
described in a Swedish patient returning from India [1]. 
Most reports on NDM are related to travellers returning 
from Pakistan and India. However, the global dispersal 
of NDM is of growing concern [2]. In the past two years, 
NDM-producing strains have been reported in patients 
returning from the African continent without obvious 
links to the Indian subcontinent [3,4]. 
Case description
A Dutch patient in their 40s was admitted to our hospi-
tal for fever and abdominal pain. On admission, com-
puted axial tomography showed a periappendicular 
abscess. Four days earlier, the patient had returned 
from holidays in Egypt with his spouse and two chil-
dren. One week into their holidays (two weeks before 
presentation at our hospital) the patient had com-
plained about right lower abdominal pain and was 
admitted to a private hospital in Egypt where 400 mg 
ciprofloxacin twice a day and 500 mg metronidazole 
three times a day were given intravenously for two 
weeks. The patient was discharged after 13 days with-
out having undergone any surgical intervention, and 
subsequently returned to the Netherlands. 
 In our hospital, the abscess was drained and the 
patient was treated with piperacilin/tazobactam 4,500 
mg three times a day intravenously for five days with 
good clinical response.
A perianal screening swab taken on admission grew 
Klebsiella pneumoniae, which was resistant to mero-
penem (minimum inhibitory concentration: 32 mg/L). 
Molecular testing of the strain by PCR and sequenc-
ing of the PCR product revealed that the strain har-
boured the gene encoding NDM-1. Molecular testing 
of faeces detected OXA-48, and culture of this sample 
grew Escherichia coli and K. pneumoniae positive for 
OXA-48.
We also screened the patient’s spouse and children, 
who had been visiting the patient in the hospital in 
Egypt. Stool samples were obtained 14 days after 
admission of the index patient. The Table shows an 
overview of the screening results for multiresistant 
microorganisms of the family. The patient, his spouse 
and the youngest child carried ESBL-producing strains 
with CTX-M1. The older child carried two different ESBL-
producing E. coli strains positive for CTX-M9. A gene 
encoding K. pneumoniae carbapenemase (KPC) was 
detected by molecular tests from faeces of the young-
est child. The culture of this sample remained negative 
for carbapenemase-producing strains. Screening of 
contact patients on the ward where the index patient 




High prevalence of ESBL-producing bacteria with rates 
of over 60% in Egyptian hospitals has been reported 
[5,6]. Also outbreaks involving OXA-48- and VIM-1 car-
bapenemase-producing strains have been described in 
the southern Mediterranean region including Egypt [7]. 
The occurrence of an NDM-1-producing Acinetobacter 
in Egypt has previously been reported, but so far no 
reports of NDM-1-producing Enterobacteriaceae could 
be found in the literature [8]. This is in contrast to other 
countries in the area such as Morocco and the United 
Arab Emirates where these bacteria have already been 
isolated [9-11].
Highly sensitive and rapid screening methods are the 
mainstay to prevent introduction of multiresistant 
microorganisms in hospitals in low prevalence coun-
tries by repatriated patients. Molecular tests that allow 
detection of carbapenemase-encoding genes directly 
from clinical samples are promising when used in addi-
tion to conventional culturing [12]. 
In the youngest child, we detected a KPC gene by two 
molecular testing methods directly from faeces, but we 
were not able to confirm these findings by culture. The 
bacterial load of the KPC- producing strain was prob-
ably too low to be cultured.
It is well recognised that repatriated patients are a risk 
for introducing multiresistant microorganisms. Family 
members attending patients hospitalised abroad may 
also be at risk of acquiring multiresistant bacteria, as 
our case illustrates. Although we cannot be sure that 
the family members picked up all strains in the hospi-
tal in Egypt, the diversity of multiresistant microorgan-
isms including strains rarely found in the Netherlands 
makes this highly plausible. Neither can we rule out 
that the strains were acquired in Egypt outside the 
hospital, since travelling to African countries has been 
described as a risk factor for ESBL carriage [13].
Based on these findings, we recommend alertness and 
compliance with isolation precautions. Infection con-
trol guidelines may need to be expanded to include 
admission screening for resistant Enterobacteriaceae in 
low prevalent counties for a growing number of inter-
national travellers, including family members who have 
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Table
Carbapenemase and/or extended-spectrum beta-lactamase-
producing strains from samples of a family returning to 

















E. coli/CTX-M1, all 
TEMsb +
E. coli/CTX-M1, all 
TEMsb except for  
TEM 104
+
E. coli/CTX-M1 (no TEM) + +
E. coli/CTX-M9 + +, +c
Resistance genes 




a  Strains phenotypically non-susceptible to third generation 
cephalosporins and/or carbapenems were tested for resistance 
genes by microarray Checkpoint chip CT103 (Checkpoints, 
Wageningen, the Netherlands). Detected ESBL-encoding genes 
(TEM-104, TEM-164, TEM-238, SHV, CTX-M) and carbapenemase-
encoding genes (KPC, NDM, OXA-48, VIM, IMP) are reported.
b  ‘All TEMs’ refers to detection of TEM-104, TEM-164 and TEM-238. 
c  Two CTX–M9 producing E. coli strains were found, which 
were phenotypically different and had distinct antimicrobial 
resistance patterns. 
d  Stool samples of all family members were tested for 
carbapenemase-encoding genes (KPC, OXA-48, VIM, NDM) by 
the microarrays Check-Direct CPE (Checkpoints, Wageningen, 




1. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et 
al. Characterization of a new metallo-beta-lactamase gene, 
bla(NDM-1), and a novel erythromycin esterase gene carried 
on a unique genetic structure in Klebsiella pneumoniae 




2. Kumarasamy K, Kalyanasundaram A. Emergence of Klebsiella 
pneumoniae isolate co-producing NDM-1 with KPC-2 from India. 
J Antimicrob Chemother. 2012;67(1):243-4. 
http://dx.doi.org/10.1093/jac/dkr431 
PMid:21990048  
3. Brink AJ, Coetzee J, Clay CG, Sithole S, Richards GA, Poirel L, 
et al. Emergence of New Delhi metallo-beta-lactamase (NDM-1) 
and Klebsiella pneumoniae carbapenemase (KPC-2) in South 
Africa. J Clin Microbiol. 2012;50(2):525-7. 
http://dx.doi.org/10.1128/JCM.05956-11 
PMid:22116157 PMCid:PMC3264190 
4. Poirel L, Benouda A, Hays C, Nordmann P. Emergence of NDM-
1-producing Klebsiella pneumoniae in Morocco. J Antimicrob 
Chemother. 2011;66(12):2781-3.  
http://dx.doi.org/10.1093/jac/dkr384 
PMid:21930570  
5. Mohamed Al-Agamy MH, El-Din Ashour MS, Wiegand I. First 
description of CTX-M beta-lactamase-producing clinical 




6. Talaat M, Hafez S, Saied T, Elfeky R, El-Shoubary W, Pimentel 
G. Surveillance of catheter-associated urinary tract infection 
in 4 intensive care units at Alexandria university hospitals in 
Egypt. Am J Infect Control. 2010;38(3):222-8. 
http://dx.doi.org/10.1016/j.ajic.2009.06.011 
PMid:19837480  
7. Poirel L, Abdelaziz MO, Bernabeu S, Nordmann P. 
Occurrence of OXA-48 and VIM-1 carbapenemase-producing 




8. Hrabak J, Stolbova M, Studentova V, Fridrichova M, 
Chudackova E, Zemlickova H. NDM-1 producing Acinetobacter 
baumannii isolated from a patient repatriated to the 
Czech Republic from Egypt, July 2011. Euro Surveill. 
2012;17(7):pii=20085. Available from: http://www.
eurosurveillance.org/ViewArticle.aspx?ArticleId=20085 
PMid:22370014  
9. Poirel L, Benouda A, Hays C, Nordmann P. Emergence of NDM-




10. Sonnevend A, Al Baloushi A, Ghazawi A, Hashmey R, Girgis S, 
Hamadeh MB, et al. Emergence and spread of NDM-1 producer 
Enterobacteriaceae with contribution of IncX3 plasmids in the 
United Arab Emirates. J Med Microbiol. 2013;62(Pt 7):1044-50 
http://dx.doi.org/10.1099/jmm.0.059014-0 
PMid:23579399  
11. Dash N, Panigrahi D, Al Zarouni M, Darwish D, Ghazawi A, 
Sonnevend A, et al. High Incidence of New Delhi Metallo-
Beta-Lactamase Producing Klebsiella pneumoniae Isolates in 
Sharjah, United Arab Emirates. Microb Drug Resist. 2013 Aug 
30. Epub ahead of print. 
http://dx.doi.org/10.1089/mdr.2013.0040 
PMid:23992285  
12. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, 
Gniadkowski M, et al. Acquired carbapenemases in Gram-
negative bacterial pathogens: detection and surveillance 
issues. Clin Microbiol Infect. 2010;16(2):112-22. 
http://dx.doi.org/10.1111/j.1469-0691.2009.03116.x 
PMid:20085605  
13. Peirano G, Laupland KB, Gregson DB, Pitout JD. Colonization 
of returning travelers with CTX-M-producing Escherichia coli. J 
Travel Med. 2011;18(5):299-303. 
http://dx.doi.org/10.1111/j.1708-8305.2011.00548.x 
PMid:21896092 
